Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study
Saved in:
| Published in: | Biologics: Targets & Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1864030189819789313 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Biologics: Targets & Therapy |
| description | |
| discipline_display | Natural Sciences |
| discipline_facet | Natural Sciences |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:18864 |
| institution | FRELIP |
| journal_source_facet | Biologics: Targets & Therapy |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study Biology Natural Sciences — Life Sciences Natural Sciences |
| sub_discipline_display | Natural Sciences — Life Sciences |
| sub_discipline_facet | Natural Sciences — Life Sciences |
| subject_display | Biology Natural Sciences — Life Sciences Natural Sciences Biology Natural Sciences — Life Sciences Natural Sciences |
| subject_facet | Biology Natural Sciences — Life Sciences Natural Sciences |
| title | Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study |
| title_auth | Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study |
| title_full | Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study |
| title_fullStr | Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study |
| title_full_unstemmed | Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study |
| title_short | Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study |
| title_sort | efficacy, safety, and cost-effectiveness of the infliximab biosimilar gp-1111 in patients with inflammatory bowel disease who underwent a nonmedical switch: a prospective cohort study |
| topic | Biology Natural Sciences — Life Sciences Natural Sciences |
| url | https://www.dovepress.com/efficacy-safety-and-cost-effectiveness-of-the-infliximab-biosimilar-gp-peer-reviewed-fulltext-article-BTT |